CareLit · DOI-Nachweis · Pneumologie
Single Inhaler Extrafine Triple Therapy improves Quality of Life in COPD Patients compared to Indacaterol/Glycopyrronium: Post-hoc Analysis of the TRIBUTE study
DOI 10.1055/s-0039-1678330
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Scuri, D Singh, LM Fabbri, I Valente, A Guasconi, S Vezzoli, H Prunier, G Cohuet, A Muraro, S Petruzzelli, A Papi
ZeitschriftPneumologie
AusgabeS 01 S 01/2019
Jahrgang / SeitenJg. 73
Kernaussage aus der Literatur
Abstract-Vorschau
Single Inhaler Extrafine Triple Therapy improves Quality of Life in COPD Patients compared to Indacaterol/Glycopyrronium: Post-hoc Analysis of the TRIBUTE study
Zitieren
Zitierempfehlung
M Scuri, D Singh, LM Fabbri, I Valente, A Guasconi, S Vezzoli, H Prunier, G Cohuet, A Muraro, S Petruzzelli, A Papi (2019) Single Inhaler Extrafine Triple Therapy improves Quality of Life in COPD Patients compared to Indacaterol/Glycopyrronium: Post-hoc Analysis of the TRIBUTE study. Pneumologie, 73 (S 01 S 01). https://doi.org/10.1055/s-0039-1678330
Mit CareLit weiterarbeiten